Literature DB >> 7504119

Disturbance of keratin homeostasis in griseofulvin-intoxicated mouse liver.

H Hutter1, K Zatloukal, G Winter, C Stumptner, H Denk.   

Abstract

BACKGROUND: Alterations of the hepatocytic intermediate filament (IF) cytoskeleton, i.e., derangement and diminution of the keratin network and appearance of cytoplasmic aggregates of keratin-containing material, termed Mallory bodies, are characteristic features of human alcoholic hepatitis. Mallory bodies can be experimentally produced in mouse liver by chronic griseofulvin (GF) administration. GF intoxication of mice is, therefore, a suitable model to study the mechanisms of Mallory body formation and related cytoskeletal changes. EXPERIMENTAL
DESIGN: To investigate the correlation between morphologic alterations of the keratin cytoskeletal network and the mRNA levels for liver keratins A (8) and D (18) in this pathologic situation immunohistochemical studies and northern blot analyses were performed. The amount of mRNA for both keratins was also analyzed by nuclease S1 protection assay.
RESULTS: In GF-treated livers (4 months of treatment) an increase of mRNA for both liver keratins was found. This increase of mRNA was unexpected under these conditions, since in longterm GF-fed animals, the amount of keratin IFs was reduced as revealed by immunofluorescence and electron microscopy and by biochemical analysis of keratin proteins. In livers treated for 2 months with GF the IF meshwork seemed to be still intact, but the increase of RNA was already detectable indicating that alterations of keratin mRNA precede detectable morphologic alterations. When using this mRNA for in vitro translation experiments, strong keratin polypeptide spots could be detected by autoradiography of 2-dimensional gels.
CONCLUSIONS: These results strongly suggest that in vivo under the conditions of GF intoxication posttranslational modifications, like phosphorylation, proteolysis and covalent cross-linking, could influence IF homeostasis and interfere with IF assembly. Increase of mRNA for liver keratins despite IF protein reduction might be due to negative feedback regulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504119

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  7 in total

1.  Analysis of intracytoplasmic hyaline bodies in a hepatocellular carcinoma. Demonstration of p62 as major constituent.

Authors:  C Stumptner; H Heid; A Fuchsbichler; H Hauser; H J Mischinger; K Zatloukal; H Denk
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  Bile acid-induced Mallory body formation in drug-primed mouse liver.

Authors:  Peter Fickert; Michael Trauner; Andrea Fuchsbichler; Conny Stumptner; Kurt Zatloukal; Helmut Denk
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Mallory body filaments become insoluble after normal assembly into intermediate filaments.

Authors:  M S Pollanen; P Markiewicz; L Weyer; M C Goh; C Bergeron
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

4.  Hepatocyte cytokeratins are hyperphosphorylated at multiple sites in human alcoholic hepatitis and in a mallory body mouse model.

Authors:  C Stumptner; M B Omary; P Fickert; H Denk; K Zatloukal
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

5.  Epiplakin is dispensable for skin barrier function and for integrity of keratin network cytoarchitecture in simple and stratified epithelia.

Authors:  Daniel Spazierer; Peter Fuchs; Siegfried Reipert; Irmgard Fischer; Matthias Schmuth; Hans Lassmann; Gerhard Wiche
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

6.  Cytokeratins as targets for bile acid-induced toxicity.

Authors:  Peter Fickert; Michael Trauner; Andrea Fuchsbichler; Conny Stumptner; Kurt Zatloukal; Helmut Denk
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

7.  Keratins turn over by ubiquitination in a phosphorylation-modulated fashion.

Authors:  N O Ku; M B Omary
Journal:  J Cell Biol       Date:  2000-05-01       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.